Received Jul 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC | PNEUMO (PREVNAR) | PFIZER\WYETH | UNK | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Patient developed shingles the day after receiving the Shingles vaccine/ rash; This non-serious case was reported by a physician via sales rep and described the occurrence of shingles in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Pneumococcal vaccine conj 7v (CRM197) (Prevnar) for prophylaxis. Concomitant products included gabapentin. On 21-JUN-2025, the patient received the 1st dose of Shingrix (unknown arm) and Prevnar. On 22-JUN-2025, 1 days after receiving Shingrix and Prevnar, the patient experienced shingles (Verbatim: Patient developed shingles the day after receiving the Shingles vaccine/ rash). The outcome of the shingles was not resolved. It was unknown if the reporter considered the shingles to be related to Shingrix and Prevnar. It was unknown if the company considered the shingles to be related to Shingrix and Prevnar. Additional Information: GSK Receipt Date: 23-JUN-2025 The patient received the first dose of Shingrix vaccine and developed shingles the day after receiving the Shingles vaccine (Shingrix) as well as the Prevnar vaccine. The Health Care Professional mentioned that patient received the Shingles vaccine and Prevnar vaccine in the same day. The doctor mentioned patient went to urgent care and received Gabapentin after rash presented.
Gabapentin